Ji‐Youn Han

机构：Baekseok Culture University, National Cancer Centre Japan, National Cancer Center, National Cancer Research Institute

发表论文 493 篇 · 总被引 25724 次 · h-index 70

代表论文

• Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy (2025 · New England Journal of Medicine · 被引 229)
• Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLC (2025 · Journal of Thoracic Oncology · 被引 7)
• Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study (2026 · Nature Communications · 被引 6)
• Longitudinal pharmacogenomic analysis of refractory lung cancer to identify therapeutic candidates for epidermal growth factor receptor–tyrosine kinase inhibitor resistance subclones (2025 · Experimental & Molecular Medicine · 被引 3)
• Asian Subgroup Analysis of Patients in the Phase 2 DeLLphi-301 Study of Tarlatamab for Previously Treated Small Cell Lung Cancer (2025 · Oncology and Therapy · 被引 2)
• Central Nervous System Outcomes of Lazertinib Treatment in EGFR-Mutated Advanced NSCLC: Pooled Analysis From LASER201 and LASER301 (2025 · Clinical Lung Cancer · 被引 2)